Fintech PR
Chiller Market to Generate Revenue of $10,880.3 Million by 2030, Globally: P&S Intelligence
Around the world, the chemical, printing, food and beverage, and pharmaceutical industries are rapidly expanding. Due to this factor, the global revenue for chiller industry is expected to grow from $7,330.7 million in 2019 to more than $10,880.3 million by 2030, at a 5.0% CAGR between 2020 and 2030. For instance, the China Cuisine Association (CCA) says that the country’s food and beverage industry size increased massively, to $636 billion (CNY 4.27 trillion), in 2018, according to P&S Intelligence.
The expanding industrial sector is driving the chiller market, as such systems are required for chemical processing, paper and cement processing, pharmaceutical formulations, X-ray diffraction systems, power generation, food and beverage processing, and welding. Similarly, chillers are widely deployed in dairies, wineries, bakeries, and breweries. Chillers are not only needed to keep the products at an optimum temperature, but also cool down the machinery.
Get the sample copy of this report at: https://www.psmarketresearch.com/market-analysis/chiller-market/report-sample
Due to the ongoing coronavirus pandemic, companies in the chiller market have been witnessing regression. Not only has the manufacturing and supply of such systems stopped due to the nationwide lockdowns around the world, but even the demand for them has reduced substantially. In the same way, the lockdown has also forced laborers to go back home, which has led to the stoppage of construction activities, which has the potential to keep the chiller demand quite low in the immediate future.
The scroll category, based on type, is predicted to keep holding the largest revenue share in the chiller market in the years to come. Offices and other such commercial buildings, as well as hospitals, generally require low-capacity chillers, which is why scroll variants have been in the highest demand.
Browse report with detailed COVID-19 impact analysis on “Chiller Market Research Report: By Type (Screw, Scroll, Centrifugal, Absorption, Reciprocating), Capacity (Water-Cooled, Air-Cooled), End-User (Commercial, Industrial, Residential) – Global Industry Analysis and Growth Forecast to 2030” at: https://www.psmarketresearch.com/market-analysis/chiller-market
In the past, the industrial category, on the basis of end-user, dominated the chiller market. In order to adopt environment-friendly practices and achieve greater operational efficiency, production plants are replacing their existing chillers with new and improved ones. Food and beverage manufacturing plants are witnessing a rapid installation of chillers, to meet the growing demand for frozen and ready-to-eat food.
Asia-Pacific (APAC) was the largest chiller market in the past, and it will contribute the highest revenue to the worldwide industry in the future as well. In China, the construction sector is expanding by leaps and bounds, due to the numerous infrastructure projects, pertaining to airports and railways, underway. Similarly, in India, data centers are being increasingly constructed, buoyed by the expanding IT industry and digitization initiatives.
Make enquiry about this report @ https://www.psmarketresearch.com/send-enquiry?enquiry-url=chiller-market
In order to keep growing in the chiller market, companies offering such equipment are expanding their product portfolio. In recent years, market players have launched chillers which:
- Come in a 40-to-230-ton capacity
- Use the R134 and R1234ze refrigerants
- Are ideal for industrial facilities and small commercial buildings
- Have a 6.3 Energy Efficiency Ratio (EER) and 9.5 European Seasonal Energy Efficiency Ratio (ESEER)
- Are integrated with two independent circuits, for partial redundancy
The major companies functioning in the global chiller market include Johnson Controls International Plc, Carrier Global Corporation, Daikin Industries Ltd., Trane Technologies Plc, Thermax Limited, Mitsubishi Electric Corporation, Midea Group Co. Ltd., Gree Electric Appliances Inc. of Zhuhai, LG Electronics Inc., and Danfoss A/S.
Browse More Reports
U.A.E. Chiller Market
U.A.E. chiller market is expected to reach $186.4 million by 2024, registering a CAGR of 5.9% during forecast period, according to P&S Intelligence. Factors including rising demand from district cooling and overall growth in the construction industry are driving the growth of the market.
https://www.psmarketresearch.com/market-analysis/uae-chiller-market
Saudi Arabia Chiller Market
Saudi Arabia chiller market is expected to reach $291.0 million by 2024, registering a CAGR of 2.7%, during the forecast period. This growth can be attributed to rising investments in the tourism-related projects, commercial infrastructure, and development in the overall hospitality sector, according to P&S Intelligence.
https://www.psmarketresearch.com/market-analysis/saudi-arabia-chiller-market
STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.
The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.
To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.
The webcast can be followed live here and a recording will be available afterwards.
Information on EQT AB’s financial reporting
The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.
The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.
Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]
Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826
The following files are available for download:
|
Invitation to presentation of EQT AB’s Q1 Announcement 2024 |
|
|
EQT AB Group |
View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html
- Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
- Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
- Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
- Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
- PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
- Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
- 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
- CEO reaffirms Kia’s commitment to ESG management
SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.
Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.
During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.
The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.
“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”
Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf
View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html
VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.
As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.
The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.
Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.
About BioVaxys Technology Corp.
BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.
ON BEHALF OF THE BOARD
Signed “James Passin“
James Passin, Chief Executive Officer
Phone: +1 646 452 7054
Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg
View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html
-
Latest News4 days ago
DEMAND AT ASIAN FACTORIES RISES AT STRONGEST RATE IN OVER 2 YEARS, IMPROVING NEAR-TERM GROWTH OUTLOOK FOR MANUFACTURING WORLDWIDE: GEP GLOBAL SUPPLY CHAIN VOLATILITY INDEX
-
Latest News4 days ago
Bitrue Gears Up for 2024 Bitcoin Halving with Trading Competition
-
Latest News5 days ago
Former Dreambox CEO Jessie Woolley-Wilson Joins Owl Ventures as Operating Partner
-
Latest News4 days ago
Global Airlines Appoints New Head of Finance from KPMG
-
Latest News4 days ago
BtcTurk Organizes Half Marathon in Istanbul to Celebrate Halving Period
-
Latest News4 days ago
Spendesk combines procurement with spend management through Okko acquisition
-
Latest News3 days ago
“The Hainan FTP and Me”: Looking at Hainan’s Transformations
-
Latest News7 days ago
Banxso Ignites Financial Markets with ‘Tour de Banxso’ Launch and High-Profile Sponsorships